TABLE 1.
Characteristics of studies included in the meta-analysis.
| Sr. no. | References | Marker | N (PTSD, HC) |
Age (PTSD, HC) |
Medicated |
| 1 | Talbot et al. (6) | TC, LDL, TG, VLDL | 94 (44, 50) |
30.55 ± 6.57, 30.34 ± 8.11 | No |
| 2 | Tae et al. (7) | HDL | 107 (68, 39) |
45.18 ± 8.05, 42.72 ± 10.0 | No |
| 3 | Jergović et al. (8) | LDL | 101 (69, 32) |
47.12 ± 5.92, 45.56 ± 7.24 | Yes |
| 4 | Dedert et al. (9) | HDL, LDL, TG | 134 (63, 71) |
41.3 ± 11.6, 39.6 ± 14 | No |
| 5 | Dennis et al. (10) | HDL | 220 (103, 117) |
30.49 ± 5.48, 27.9 ± 5.52 | No |
| 6 | Karlovic et al. (11) | TC, HDL, LDL, TG | 82 (43, 39) |
41.3 ± 8.3, 43.8 ± 10.1 | Yes |
| 7 | Karlovic et al. (12) | TC, HDL, LDL, TG | 102 (53, 49) |
34 ± 5.4, 35 ± 4.3 | Yes |
| 8 | Kulenović et al. (13) | TC, HDL, LDL, TG, VLDL | 100 (50, 50) |
45, 45 | No |
| 9 | Maia et al. (14) | TC, LDL, TG | 101 (11, 90) |
35.73 ± 7.12, 33.11 ± 5.38 | NA |
| 10 | Lihua et al. (15) | HDL, TG | 2,867 (201, 2,666) |
25, 35 | NA |
| 11 | Hamazaki et al. (16) | HDL, LDL | 30 (15, 15) |
47 ± 16, 36 ± 15 | NA |
| 12 | de Vries et al. (17) | TC, LDL | 94 (49, 45) |
46 ± 10.4, 46.6 ± 10 | Yes |
| 13 | Linnville et al. (18) | TG | 154 (89, 65) |
61 ± 6, 61 ± 6 | NA |
| 14 | Ahmadi et al. (5) | TC, HDL | 637 (88, 549) |
59 ± 9, 58 ± 10 | NA |
| 15 | Su et al. (19) | TC, TG | 709 (75, 634) |
17 ± 0.61, 16.9 ± 0.58 | NA |
| 16 | Ansari and Ahmed (37) | TC | 65 (50, 15) |
35.1 ± 1.6, 35.1 ± 1.6 | NA |
| 17 | McLeay et al. (95) | TG | 214 (108, 106) |
68.5 ± 4.1, 69.2 ± 4.2 | NA |
PTSD, post-traumatic stress disorder; HC, healthy control; TC, total cholesterol; LDL, low density-lipoprotein; HDL, High density lipoprotein; TG, triglyceride; VLDL, very low density lipoprotein; NA, not available.